Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target

被引:5
|
作者
Mukherjee, Sumanta [1 ]
Lukacs, Nicholas W. [2 ]
机构
[1] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI USA
关键词
TYPE-2 CYTOKINE PRODUCTION; AIRWAY HYPERRESPONSIVENESS; TH2; CYTOKINES; CHILDHOOD ASTHMA; VIRAL-INFECTIONS; NOTCH LIGAND; EARLY-LIFE; BRONCHIOLITIS; RISK; AGE;
D O I
10.1586/ERI.10.39
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:617 / 621
页数:5
相关论文
共 50 条
  • [1] Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen
    Park, JW
    Taube, C
    Yang, ES
    Joetham, A
    Balhorn, A
    Takeda, K
    Miyahara, N
    Dakhama, A
    Donaldson, DD
    Gelfand, EW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (06) : 1078 - 1087
  • [2] Innate IL-13 in virus-induced asthma?
    Cormier, Stephania A.
    Kolls, Jay K.
    NATURE IMMUNOLOGY, 2011, 12 (07) : 587 - 588
  • [3] Innate IL-13 in virus-induced asthma?
    Stephania A Cormier
    Jay K Kolls
    Nature Immunology, 2011, 12 : 587 - 588
  • [4] IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge
    Johnson, TR
    Parker, RA
    Johnson, JE
    Graham, BS
    JOURNAL OF IMMUNOLOGY, 2003, 170 (04): : 2037 - 2045
  • [5] IL-13 as a therapeutic target for respiratory disease
    Kasaian, Marion T.
    Miller, Douglas K.
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (02) : 147 - 155
  • [6] IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease
    Petersen, Bryan C.
    Dolgachev, Vladislav
    Rasky, Andrew
    Lukacs, Nicholas W.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 95 (05) : 809 - 815
  • [7] IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease
    Castilow, Elaine M.
    Meyerholz, David K.
    Varga, Steven M.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (04): : 2376 - 2384
  • [8] IL-13: A promising therapeutic target for bronchial asthma
    Izuhara, K.
    Arima, K.
    Kanaji, S.
    Ohta, S.
    Kanaji, T.
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (19) : 2291 - 2298
  • [9] Respiratory syncytial virus-induced immunoprotection and immunopathology
    Durbin, JE
    Durbin, RK
    VIRAL IMMUNOLOGY, 2004, 17 (03) : 370 - 380
  • [10] IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse
    Zhou, Weisong
    Hashimoto, Koichi
    Moore, Martin L.
    Elias, Jack A.
    Zhu, Zhou
    Durbin, Joan
    Colasurdo, Giuseppe
    Rutigliano, John A.
    Chiappetta, Constance L.
    Goleniewska, Kasia
    O'Neal, Jarnye F.
    Graham, Barney S.
    Peebles, R. Stokes, Jr.
    MICROBES AND INFECTION, 2006, 8 (14-15) : 2880 - 2889